University of Massachusetts
Worcester, Massachusetts, United States
Jae-Hyuck Shim, Ph.D is a Tenured Associate Professor of Medicine/Horae Gene Therapy Center and the Director of Bone Analysis Core and Musculoskeletal Gene Therapy Program at the UMass Chan Medical School. He received his Bachelor/Master degrees from Yonsei University (Biotechnology) in Korea. In 2000, he moved to Yale School of Medicine (Immunobiology) for his PhD degree and completed his postdoctoral and instructor training in Harvard School of Public Health. In 2012, he was appointed as an assistant professor of the Pathology and Laboratory Medicine at the Weill Cornell Medicine, New York and moved to the UMass Chan Medical School in 2016. Using his unique cross-disciplinary combination of gene therapy, immunology, and skeletal biology, Dr. Shim strives to develop novel gene therapeutics for human skeletal diseases, including fibrodysplasia ossificans progressiva (FOP). He co-founded AAVAA Therapeutics Inc that develops new gene therapeutics for the rare skeletal disease FOP.
Molecular Mechanisms Underlying Inflammatory Joint Damage
Saturday, November 16, 2024
4:00 PM – 4:30 PM Eastern Time
Disclosure(s): AAVAA Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Samsung Biologics and Bioepis: Consultant (Ongoing)